Operator‑led capital for the
AI transformation
of healthcare.
We back defensible healthcare and health-tech businesses and build value hands‑on—
alongside founders and management.
A Diversified Private Equity Healthcare Fund
Operators who invest
Ainsley MacLean, MD, FACR
General Partner
Founding Partner of Ainsley Advisory Group, a firm advising more than 25 healthcare AI technology companies on go-to-market strategies, and a healthcare and health tech investor. Former CAIO/CMIO at Kaiser Permanente, where she led large-scale AI deployments and digital innovation initiatives to improve provider workflows and patient outcomes. Dr. MacLean also founded the Permanente AI Center of Excellence and advised on the organization’s first national AI strategy. A Harvard-trained neuroradiologist, she brings deep clinical and academic expertise to ensure AI-driven innovation remains grounded in real-world care delivery.
Greg Born,
MBA
General Partner
Operator-investor focused on healthcare services & health-tech. Led $3B+ in M&A and value-creation programs across PE-backed and growth companies, with a playbook spanning strategy, operational excellence, sales ops, and clinical integration. As Interim CEO at Osso VR, he reduced burn ~60% and reopened enterprise channels; as President/COO at MDsave, he delivered +$6MM run-rate EBITDA, launched three products, led a B2B pivot leading to a successful sale. Built post-merger integration at Change Healthcare (~$1.4B acquisitions) & helped lead $500MM roll-ups at USAP. A USAF Academy grad & former C-5 Galaxy instructor pilot, previously held leadership roles at Amazon, Oracle, & GE and serves on boards & as a founder partner.
Partners and Advisors
Nadia Smati,
MD
Partner
Board-certified internal medicine physician with dual U.K. and U.S. clinical training, with training from Kaiser Permanente and NHS England and education from Stanford University and Imperial College London. Her work focuses on advancing the integration, deployment, and governance of AI and digital technologies in healthcare, advising health systems and technology companies on responsible implementation and strategies to enhance adoption, safety, and impact.
Mohammad Malik, MBA
Partner
Senior healthcare executive with over two decades of experience in healthcare operations, AI deployment, medical imaging, enterprise strategy, and capital medical equipment. Mohammad previously led technology deployment and infrastructure development at Kaiser Permanente. He now advises healthcare AI and medical imaging companies on market strategy, regulatory navigation, and enterprise adoption
Jerry Daneshvar,
MD
Investor Relations
Physician–executive who partners with healthcare leaders and venture-backed startups to bring breakthrough technologies to market. His work spans plasma medicine, gene therapy, medical devices, and AI. Based in Washington, D.C., he builds senior relationships across industry, academia, and government, leveraging a trusted network to accelerate innovation for Ainsley & Born Capital.
Savitha Srinivasan, MBA
Advisor
Board-level tech & M&A leader (IBM, 8x8, Trace3) in digital health/AI—adds Make-Buy-Partner rigor, corporate VC access, and go-to-market partnerships for portfolio companies.
David Samuels,
MBA
Advisor
Six-time CFO (Fortune 500 + PE-backed) with $1B+ structured debt & equity experience; brings capital strategy, M&A integration, and operating discipline to portfolio companies.
Craig Robinson,
MBA
Advisor
Practice Leader in Truist Wealth’s Foundations and Endowments Specialty Practice, overseeing more than $2 billion in assets across long- & short-term mandates for institutional investors. Extensive expertise in capital deployment & portfolio strategy, with a strong track record in fund formation, administration, distribution.
Tyler Berzin,
MD
Clinical Advisor
Harvard Medical School Associate Professor and Director of Advanced Endoscopy, Dr.Berzin is a leading GI specialist and advisor. He has authored over 175 publications and led pioneering U.S. and international trials in AI-assisted endoscopy, contributing to several FDA-cleared technologies. He advises medical device companies, digital health ventures, and investment firms.
Joanna MacLean, MD
Clinical Advisor
Harvard-trained psychiatrist and Director of Women’s Behavioral Medicine at Brown University Health, and Associate Professor of Psychiatry, Human Behavior, and Medicine. Dr. MacLean’s work focuses on women’s mental health across the reproductive years and the integration of behavioral health into primary care and obstetric settings. She serves on the national task force on women’s reproductive mental health.
Sara Eversden,
MBA
Clinical Advisor
SVP, Women & Children’s Ops (Envision); former market president/CEO (Women’s Health USA) and oncology finance leader (McKesson). Brings multi-site operations, hospital contracting, RCM, and post-merger integration rigor to portfolio companies.
Not an offer to sell securities. Past performance is not indicative of future results.
© 2025 Ainsley & Born Capital. All rights reserved.